← All stocks

BALCHEM CORP

BCPC No buying or selling
CIK 0000009326 #1260 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

16 insiders · 0 transactions
11.7×

Ted Harris holds 11.7 times base salary in stock. $14.05M of shares against $1.20M in salary for 2025.

Salary from the company's own proxy. The shares are what Ted Harris last reported holding, valued at $153.80, the price Common Stock was last bought or sold at on the open market here, on 4 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Harris Theodore L
Chairman, President & CEO
91,373
$14.05M
+41.2%
Bengtsson Carl Martin
EVP & Chief Financial Officer
27,926
$4.30M
+47.4%
Tignor Michael Brent
SVP & Chief HR Officer
10,723
$1.65M
+50.7%
van Gunsteren Job Leonard
SVP and GM, Specialty Products
10,149
$1.56M
+18.8%
Reid Martin Luther
SVP Chief Supply Chain Officer
9,073
$1.40M
+49.2%
Boned Frederic
SVP/GM, Human Nutri. & Health
8,978
$1.38M
+74.3%
Fischer David B
Director
8,859
$1.36M
−1.7%
Miyata Hatsuki
EVP, CLO, & Secretary
8,745
$1.35M
+81.0%
Wineinger Matthew David
Director
8,012
$1.23M
+30.0%
Knutson Daniel E
Director
6,899
$1.06M
+36.6%
Backus William A.
VP & Chief Accounting Officer
6,736
$1.04M
+35.0%
Sestrick Michael Robert
SVP & Chief Technology Officer
4,762
$732.41K
+16.3%
Fish Kathleen B
Director
3,429
$527.39K
+117.2%
Graham George
SVP and Chief R&D Officer
3,200
$492.17K
Rigaud Olivier
Director
2,390
$367.59K
+342.6%
VICENTE MONICA
Director
2,390
$367.59K
+342.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 2 Sep 2016